The time required for precipitation of cholesterol crystals (nucleation time, NT) was determined and related to the cholesterol saturation in gall bladder bile of gall stone free subjects (n=11), patients with pigment stones (n=3), and patients with cholesterol gall stones (n=30) undergoing cholecystectomy. Seven of the gall stone patients had been treated with chenodeoxycholic acid (CDCA) and nine with ursodeoxycholic acid (UDCA), 15 mg/kg/day for three weeks before operation. NT was longer in gail stone free subjects (mean, 20 days), patients with pigment stones (14 days) and patients treated with CDCA (24 days) and UDCA (17 days) compared with untreated patients with cholesterol gall stones (1.5 days). In spite of low cholesterol saturation and prolonged NT, and in contrast to those treated with CDCA, four of the nine patients treated with UDCA had cholesterol crystals in their bile. These observations give further support to the concept that the mechanism for inducing gall stone dissolution may be different for CDCA and UDCA.
Bile, supersaturated with cholesterol, is a prerequisite but not the only requirement for gall stone formation in humans.' In order to explain why gall stone free subjects also frequently have an excess of cholesterol in their bile,'-' Holan et al' have introduced the concept of nucleation time (NT) -defined as the time required for cholesterol precipitation in vitro as monohydrated cholesterol crystals in centrifuged and particle-free bile (NT could also be called the cholesterol microcrystal appearance/detection time). NT is the only parameter which discriminates cholesterol stone bile from normal bile with the same cholesterol saturation index. The short NT in cholesterol gall stone patients is considered to be due to an imbalance between nucleating and antinucleating agent(s).'
In 1972 it was shown that treatment with chenodeoxycholic acid (CDCA) may result in the dissolution of cholesterol gall stones.67 A year later, the first report on gall stone dissolution with ursodeoxycholic acid (UDCA) was published.8 These two drugs have now become accepted as tools in the treatment of gall stones. Although the mode of action is somewhat different, both bile acids decrease biliary cholesterol secretion and thus the cholesterol saturation index of bile. 9 It has recently been reported that UDCA significantly prolongs NT in cholesterol gall stone patients,'0 whereas the effect of CDCA in this respect is not known.
Sweden has a comparatively high incidence of cholesterol gall stone disease but the knowledge of its pathogenesis is limited. The enhanced cholesterol saturation of bile appears to be due mainly to an absolute increase in the secretion rate of cholesterol from the liver, whereas the secretion rates of bile acids and phospholipids are normal. '2 The aims of this study were twofold: to determine the NT of gall bladder bile in Swedish gall stone patients and gall stone free subjects, and to study the influence of treatment with CDCA and UDCA in doses known to make bile unsaturated with cholesterol in gall stone patients.
Materials and methods

PATIENTS
Forty four patients undergoing elective cholecystectomy were studied: 11 without and 33 with gall stones, three of whom had pigment stones (Table I) gall stone free subjects was seven to eight times teoxycholic acid (UDCA) or chenodeoxycholic acid longer than that in cholesterol gall stone patients, CA) and pigment gall stone patients (PIGM).
although the gall stone free subjects in that study also had saturated bile (mean cholesterol saturaents with untreated cholesterol gall stones tion, 112%) It is thus evident that not only 4)), 1/11 gall stone free subjects, 4/9 UDCA cholesterol saturation but also other factors are of ted and 1/7 CDCA treated patients, and in importance for the nucleation process. e of the three patients with pigment stones Another important finding of the present ble II). The difference between the untreated study was that the treatment ofgall stone patients lesterol gall stone group and the gall stone with a relatively high dose of UDCA, making gall group was significant (p<0 001).
bladder bile unsaturated with cholesterol, pro-TT was significantly shorter in the gall stone longed the NT to about the same level as that ap compared with the gall stone free group seen in gall stone free subjects. This confirms (0.3) days v 20 (3) days, p<0.0001) (Table and extends the observation of two recent Only one gall stone free subject had a short studies.'0 Thus, Tazuma et al ' found a pro- (Fig 1) . Treatment with CDCA and UDCA longed NT in gall stone patients who had been longed NT to 24 (6) days and 17 (3) days treated with UDCA (300-600 mg/day) for three ble II, Fig 1) Ider bile was lower in the gall stone free group compared to 45% in our study. Jungst et all' lpared with the untreated cholesterol gall also found a prolonged NT (12 days) in gall stone le group (79 (10) v 111 (10)%, p<0.05), patients treated with a low dose of UDCA Lough there was a certain overlap (Fig 2) . Gall (250 mg) for a short period of time, 6-10 days. lder bile was unsaturated in all the patients The biliary cholesterol saturation in that study ited with CDCA (63 (7)%) and UDCA (50 averaged 94%. Thus we can conclude that both Jo or 67 (9)% with Carey's correction factor) low and high dose UDCA prolongs NT in gall 2, Table II 
